These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11847403)

  • 21. [Intensive anti-platelet treatment: a new viewpoint in reperfusion strategy for ST segment elevation myocardial infarction].
    Huo Y; Chen M
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1091-2. PubMed ID: 16796831
    [No Abstract]   [Full Text] [Related]  

  • 22. Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review".
    Howlett M
    MedGenMed; 2002 Feb; 4(1):6; author reply 7. PubMed ID: 11965208
    [No Abstract]   [Full Text] [Related]  

  • 23. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotics and antiplatelets in acute myocardial infarction.
    Wander GS; Gupta NK
    Indian Heart J; 2011; 63(1):58-65. PubMed ID: 23189866
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
    Morrow DA; Antman EM; Murphy SA; Qin J; Ruda M; Guneri S; Jacob AJ; Budaj A; Braunwald E;
    Am Heart J; 2007 Dec; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of ST elevation myocardial infarction: a review of the recent literature and practice guidelines.
    Hahn SA; Chandler C
    Mt Sinai J Med; 2006 Jan; 73(1):469-81. PubMed ID: 16470326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between mortality due to acute myocardial infarction and adherence to clinical guidelines].
    Coma-Canella I
    Rev Esp Cardiol; 2006 Mar; 59(3):189-92. PubMed ID: 16712740
    [No Abstract]   [Full Text] [Related]  

  • 28. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction.
    Zaman AG
    N Engl J Med; 2003 Nov; 349(22):2167-9; author reply 2167-9. PubMed ID: 14658128
    [No Abstract]   [Full Text] [Related]  

  • 30. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines for pre-hospital administration of fibrinolytic therapy in New Zealand general practitioners.
    Pre-Hospital Fibrinolysis Guidelines Working Party
    N Z Med J; 2004 Jul; 117(1197):U958. PubMed ID: 15326511
    [No Abstract]   [Full Text] [Related]  

  • 32. Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategy.
    Cannon CP; Turpie AG
    Circulation; 2003 Jun; 107(21):2640-5. PubMed ID: 12782615
    [No Abstract]   [Full Text] [Related]  

  • 33. 2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice.
    Pollack CV; Antman EM; Hollander JE; ;
    Ann Emerg Med; 2008 Oct; 52(4):344-355.e1. PubMed ID: 18519158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.
    Hilleman DE; Tsikouris JP; Seals AA; Marmur JD
    Pharmacotherapy; 2007 Nov; 27(11):1558-70. PubMed ID: 17963464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombolysis in acute myocardial infarction: current status.
    Kiernan TJ; Gersh BJ
    Med Clin North Am; 2007 Jul; 91(4):617-37; x. PubMed ID: 17640539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of platelets and platelet inhibition in acute myocardial infarction.
    Valettas N; Herrmann HC
    Coron Artery Dis; 2003 Aug; 14(5):357-63. PubMed ID: 12878900
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic reperfusion strategies for the treatment of ST-segment elevation myocardial infarction.
    Young JJ; Kereiakes DJ
    Rev Cardiovasc Med; 2003; 4(4):216-27. PubMed ID: 14668689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk stratification in the acute coronary syndrome. Diabetes--a diagnostic dilemma].
    Giannitsis E; Katus HA
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S211-4. PubMed ID: 17109251
    [No Abstract]   [Full Text] [Related]  

  • 40. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.